Extended-protected article

Long COVID

Source: Wikipedia, the free encyclopedia.

Long COVID is a condition characterized by long-term consequences persisting or appearing after the typical convalescence period of COVID-19. It is also known as post-COVID-19 syndrome, post-COVID-19 condition,[1][2] post-acute sequelae of COVID-19 (PASC), or chronic COVID syndrome (CCS).[3][4][5] Long COVID can affect nearly every organ system, with sequelae including respiratory system disorders, nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, musculoskeletal pain, and anemia.[6] A wide range of symptoms are commonly reported, including fatigue, malaise, headaches, shortness of breath, anosmia (loss of smell), parosmia (distorted smell), muscle weakness, low fever and cognitive dysfunction.[7]

The exact nature of symptoms and the number of people who experience long-term symptoms are unknown; these vary according to the definition used, the population being studied, and the time period used in the study. A survey by the UK Office for National Statistics estimated that about 14% of people who tested positive for SARS-CoV-2 experienced one or more symptoms for longer than three months.[8] A study from the University of Oxford of 273,618 survivors of COVID-19, mainly from the United States, showed that about 37% experienced one or more symptoms between three and six months after diagnosis.[9]

While studies into various aspects of long COVID are under way,[10][11] as of November 2021, the definition of the illness is still unclear, as is its mechanism. Health systems in some countries and jurisdictions have been mobilized to deal with this group of patients by creating specialized clinics and providing advice.[12][13][14] Overall, however, it is considered by default to be a diagnosis of exclusion.[15]

A review suggests that global prevalence of long COVID conditions after infection could be as high as 43%, with the most common symptoms being fatigue and memory problems.[16][17]

Terminology and definitions

Overview

Long COVID is a patient-created term which was reportedly first used in May 2020 as a hashtag on Twitter by Elisa Perego, an archaeologist at University College London.[18][19]

Long COVID has no single, strict definition.[20][21] It is normal and expected that people who experience severe symptoms or complications such as post-intensive care syndrome or secondary infections will take longer to recover than people who did not require hospitalization (called mild COVID-19[22]) and had no such complications. It can be difficult to determine whether an individual's set of ongoing symptoms represents a normal, prolonged convalescence, or extended 'long COVID'. One rule of thumb is that long COVID represents symptoms that have been present for longer than two months, though there is no reason to believe that this choice of cutoff is specific to infection with the SARS-CoV-2 virus.[20]

World Health Organization clinical case definition

The World Health Organization (WHO) established a clinical case definition in October 2021,[1] published in the journal The Lancet Infectious Diseases:[2]

post-COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include, but are not limited to, fatigue, shortness of breath, and cognitive dysfunction, and generally have an impact on everyday functioning. Symptoms might be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms might also fluctuate or relapse over time.

British definition

The British National Institute for Health and Care Excellence (NICE) divides COVID-19 into three clinical case definitions:

  • acute COVID-19 for signs and symptoms during the first four weeks after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the first, and
  • long Covid for new or ongoing symptoms four weeks or more after the start of acute COVID-19, which is divided into the other two:
    • ongoing symptomatic COVID-19 for effects from four to twelve weeks after onset, and
    • post-COVID-19 syndrome for effects that persist 12 or more weeks after onset.

NICE describes the term long COVID, which it uses "in addition to the clinical case definitions", as "commonly used to describe signs and symptoms that continue or develop after acute COVID-19. It includes both ongoing symptomatic COVID-19 (from four to twelve weeks) and post-COVID-19 syndrome (12 weeks or more)".[23]

NICE defines post-COVID-19 syndrome as "Signs and symptoms that develop during or after an infection consistent with COVID‑19, continue for more than 12 weeks and are not explained by an alternative diagnosis. It usually presents with clusters of symptoms, often overlapping, which can fluctuate and change over time and can affect any system in the body. Post‑COVID‑19 syndrome may be considered before 12 weeks while the possibility of an alternative underlying disease is also being assessed".[23]

American definition

In February 2021, the U.S. National Institutes of Health (NIH) director Francis Collins indicated long COVID symptoms for individuals who "don't recover fully over a period of a few weeks" be collectively referred to as "Post-Acute Sequelae of SARS-CoV-2 Infection" (PASC). The NIH listed long COVID symptoms of fatigue, shortness of breath, brain fog, sleep disorders, intermittent fevers, gastrointestinal symptoms, anxiety, and depression. Symptoms can persist for months and can range from mild to incapacitating, with new symptoms arising well after the time of infection.[24] The Centers for Disease Control and Prevention (CDC) term Post-Covid Conditions qualifies long Covid as symptoms four or more weeks after first infection.[25]

Symptoms

A scientific review identified over 50 apparent long-term effects – including those of 'long COVID' – along with their estimated prevalence and estimated that 80% of included patients had at least one overall effect beyond two weeks.[26][27]

A multinational online survey with 3,762 participants with illness lasting more than 28 days found that recovery takes longer than 35 weeks for 91% of them. On average, participants experienced 56 symptoms (standard deviation ± 25.5) in nine organ systems. Symptoms varied over time, and the most common symptoms after six months were fatigue, post-exertional malaise and cognitive dysfunction.[28]

Symptom relapse occurred in 86% of participants triggered by physical or mental effort or by stress. Three groups of symptoms were identified: initial symptoms that peak in the first two to three weeks and then subside; stable symptoms; and symptoms that increase markedly in the first two months and then stabilize.[28]

Symptoms reported by people with long COVID include:[29][30][31][32][33][6][34]

Epidemiology

Some reports of long-term illness after infection appeared early during the COVID-19 pandemic,[38][39] including in people who had a mild (not requiring hospitalization[40]) or moderate (requiring oxygen supplementation[40]) initial infection[41] as well as those who were admitted to hospital with more severe infection.[42][43][scientific citation needed] In a 4-year survey following SARS in Hong Kong, 42.5% of survivors reported at least one diagnosable psychiatric disorder ranging from post-traumatic stress disorders, depression, and chronic fatigue.[44]

As of January 2021, the precise incidence was unknown. The incidence declines over time as many people slowly recover. Some early studies suggested that between 20% and 33% of people with COVID-19 experienced symptoms lasting longer than a month.[45][46] A telephone survey in the U.S. in the first half of 2020 showed that about 35% of people who had tested positive for SARS-CoV-2 experienced a range of symptoms that lasted longer than three weeks.[46] As of December 2020, the Office of National Statistics in the UK estimated that, of all people with a positive test for SARS-CoV-2, about 21% experienced symptoms for longer than five weeks, and about 10% experienced symptoms for longer than 12 weeks.[45][47][48]

Some studies have suggested that some children experience lingering symptoms of SARS-CoV-2 infection.[45][49][50]

Although anyone who gets infected can develop long COVID, people who become so sick that they require hospitalization take longer to recover. A majority (up to 80%[51]) of those who were admitted to hospital with severe disease experience long-term problems including fatigue and shortness of breath (dyspnoea).[39][52][53] Patients with severe initial infection, particularly those who required mechanical ventilation to help breathing, are also likely to suffer from post-intensive care syndrome following recovery.[42]

A study of patients who had been hospitalised in Wuhan found that the majority still had at least one symptom after six months. Patients who had been more severely ill still showed severe incapacity in lung function.[32] Among the 1733 patients who had been discharged from hospital and followed up about six months later, the most common symptoms were fatigue or muscle weakness (63%), sleep difficulties (26%), and anxiety or depression (23%).[54]

Some people suffer long-term neurologic symptoms despite never having been hospitalized for COVID-19; the first study of this population was published in March 2021. Most frequently, these non-hospitalized patients experienced "prominent and persistent 'brain fog' and fatigue that affect their cognition and quality of life."[55][56]

A January 2021 study of UK patients hospitalized for COVID-19 and discharged in 2020 reported that within 140 days, 29% were readmitted to hospital, and 12% of the discharged total had died. Cardivascular and respiratory problems were common, and 5% of patients developed diabetes for the first time.[57]

In March 2021, the Indonesian Doctors Association, in a survey of 463 people, suggested that 63.5% of respondents self-reported lingering symptoms after SARS-CoV-2 infection. The exact set of symptoms was not specified; however, according to the article, fatigue and cough were the most commonly reported symptoms, followed by muscle pain and headache.[58]

In May 2021, a global systematic review led by researchers at Stanford University reported that a wide variety of symptoms persisted in more than 70% of COVID-19 patients months after recovering from the initial phase of the disease. Most patients in this study were previously hospitalized. The most common lingering symptoms included shortness of breath, fatigue, and sleep disorders. The study reported 84 clinical signs or symptoms, including loss of taste and smell, cognitive disorders such as memory loss and difficulty concentrating, depression, and anxiety.[59]

In June 2021, a long-term study in Bergen, Norway, found 52% (31/61) of a cohort of home-isolated young adults cases, ages 16–30, continued to experience symptoms at six months. The study captured 82% (312) of the pandemic first wave cases: 247 home-isolated and 65 hospitalized.[60][61]

In August 2021, a study of 1,276 hospital survivors of the early 2020 outbreak in Wuhan reported that, while many symptoms disappeared over time and 88% of those previously employed returned to their original work, 49% of them had at least one sequela 12 months after discharge from the hospital, and the general health status of the group was lower than that of the control population. Women had a greater chance of fatigue, muscle weakness, anxiety, depression, or impaired lung diffusion than men. The study also found that survivors are at greater risk for psychiatric outcomes such as anxiety and depression.[62]

At first, there was little data on long COVID following breakthrough infections (cases in fully vaccinated people).[63] In July 2021, a study with 1,497 fully vaccinated healthcare professionals in Israel reported that 19% of those testing positive (7 out of 36 infected people) also had long COVID-19 symptoms at 6 weeks or more, with the Alpha variant identified in 85% of positive cases.[64] A September 2021 study published in The Lancet found that having two doses of a COVID-19 vaccine halved the odds of long COVID.[65] However, a May 2022 study published by Nature that examined VA Saint Louis Health Care System records from January to December 2021 of more than 13 million people, including 34,000 people vaccinated against COVID-19 who had breakthrough infections, found that COVID-19 vaccination reduced long COVID risk by about 15%.[66]

A October 2021 meta-analysis showed that more than 60% of individuals infected by SARS-CoV‑2 exhibited at least one post-COVID-19 symptom after onset or hospital admission.[67]

Causes

It is currently unknown why most people recover fully within two to three weeks and others experience symptoms for weeks or months longer.[68] Although the exact processes that cause long COVID remain unknown, a number of mechanisms have been suggested.

A March 2021 review article cited the following pathophysiological processes as the predominant causes of long COVID:[69]

  • direct toxicity in virus infected tissue, especially the lungs
  • ongoing inflammation due to post-infection immune system dysregulation
  • vascular injury and ischemia caused by virus induced hypercoagulability (tendency to form internal clots) and thromboses (internal blood clots)
  • impaired regulation of the renin-angiotensin system related to the effect of SARS-CoV-2 on ACE2 containing tissue

In October 2020, a review by the United Kingdom's National Institute for Health Research hypothesized that ongoing long COVID symptoms may be due to four syndromes:[39][70]

Other situations that might cause new and ongoing symptoms to include:

Similarities to other syndromes

Long COVID is similar to post-Ebola syndrome and the post-infection syndromes seen in chikungunya and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often triggered by infection and immune activation and was previously also known as "post-viral fatigue". The pathophysiology of long COVID may be similar to these other conditions.[20] Some long COVID patients in Canada have been diagnosed with ME/CFS, a "debilitating, multi-system neurological disease that is believed to be triggered by an infectious illness in the majority of cases". Lucinda Bateman, a US specialist in ME/CFS in Salt Lake City, believes that the two syndromes are identical. There is need for more research into ME/CFS; Anthony Fauci, chief medical adviser to the US government, said that COVID-19 is a "well-identified etiologic agent that should be very helpful now in getting us to be able to understand [ME/CFS]".[76]

Risk factors

According to a King's College London study initially posted on 21 October 2020 risk factors for long COVID may include:[77][78][79]

  • Age – particularly those aged over 50
  • Obesity[80]
  • Asthma
  • Reporting more than five symptoms (e.g., more than a cough, fatigue, headache, diarrhoea, loss of sense of smell) in the first week of COVID-19 infection; five is the median number reported

Women are less likely to develop severe acute COVID but more likely to develop long COVID than men.[20] Some research suggests this is due primarily to hormonal differences,[81][82] while other research points to other factors, including chromosomal genetics, sex-dependent differences in immune system behavior, and non-biological factors may be relevant.[20]

Diagnosis

Xenon MRI is being used to study long COVID, because it provides patients and physicians with explanations for previously unexplained observations. Xenon MRI can measure gas exchange and provide information on how much air is taken up by a patient's bloodstream, which is being researched in long-haul COVID patients.[83][84]

Xenon MRI can quantify three components of lung function: ventilation, barrier tissue uptake and gas exchange. Xenon-129 is soluble in pulmonary tissue, which allows the evaluation of lung functions such as perfusion and gas exchange (an advantage over helium). Ventilation measures how the air is distributed in the lung and can provide the locations of potentially compromised lung areas if no xenon reaches those areas. Barrier tissue uptake and gas exchange measure how much air diffuses across the alveolar-capillary membrane. Xenon MRI helps determine how well air is taken in by the lungs, absorbed into lung tissue, and taken up by the blood.[85][84]

Health system responses

Australia

In October 2020, a guide published by the Royal Australian College of General Practitioners (RACGP) says that ongoing post-COVID-19 infection symptoms such as fatigue, shortness of breath and chest pain will require management by GPs, in addition to the more severe conditions already documented.[51]

In December 2021, research by a health economics expert at Deakin University suggests that even without fully understanding the Omicron variant's effects yet, a further 10,000 to 133,000 long COVID cases are likely to emerge on top of the current approximately 9450 in New South Wales and 19,800 in Victoria, after border and other restrictions had been recently lifted. The RACGP released new guidelines for general practitioners to manage a large number of new long COVID patients.[86]

South Africa

In October 2020, the DATCOV Hospital Surveillance Department of the National Institute for Communicable Diseases (NICD) looked into a partnership with the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) (an open-access research and data resource)[87] in order to conduct clinical research into the impact PASC may have within the South African context. As of 30 January 2021, the project has yet to receive ethical approval for the commencement of data collection. Ethics approval was granted on 3 February 2021 and formal data collection began on 8 February 2021.[citation needed]

United Kingdom

In Britain, the National Health Service set up specialist clinics for the treatment of long COVID.[88] The four Chief Medical Officers of the UK were warned of academic concern over long COVID on 21 September 2020 in a letter written by Trisha Greenhalgh published in The BMJ[89] signed by academics including David Hunter, Martin McKee, Susan Michie, Melinda Mills, Christina Pagel, Stephen Reicher, Gabriel Scally, Devi Sridhar, Charles Tannock, Yee Whye Teh, and Harry Burns, former CMO for Scotland.[89]

In October 2020, NHS England's head Simon Stevens announced the NHS had committed £10 million to be spent that year on setting up long COVID clinics to assess patients' physical, cognitive, and psychological conditions and to provide specialist treatment. Future clinical guidelines were announced, with further research on 10,000 patients planned and a designated task-force to be set up, along with an online rehabilitation service[90] – "Your Covid Recovery".[91] The clinics include a variety of medical professionals and therapists, with the aim of providing "joined-up care for physical and mental health".[48]

The National Institute for Health Research has allocated funding for research into the mechanisms behind symptoms of Long COVID.[48][10]

In December 2020, University College London Hospitals (UCLH) opened a second Long Covid clinic at the National Hospital for Neurology and Neurosurgery for patients with post-Covid neurological issues. The first clinic had opened in May, primarily focused on respiratory problems, but both clinics refer patients to other specialists where needed, including cardiologists, physiotherapists and psychiatrists.[92] By March 2021 there were 69 long covid clinics in the English NHS. mostly focussing on assessing patients, with more planned to open. There were fears that community rehabilitation services did not have capacity to manage large numbers of referrals.[93]

On 18 December 2020, the National Institute for Health and Care Excellence (NICE), the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) published a guide to the management of Long COVID.[94] The guideline was reviewed by representatives of the UK doctors #longcovid group, an online support group for long covid haulers, who said that it could be improved by introducing a more comprehensive description of the clinical features and physical nature of long COVID, among other changes.[95]

In November 2021 complaints were reported from NHS staff that neither their employers nor their trades unions were supportive, though the British Medical Association was pushing for long-covid to be classed as an occupational disease.[96]

In May 2022 demand for occupational therapy led rehabilitation services in Britain was reported to have increased by 82% over the previous six months as occupational therapists were supporting people whose needs have become more complex because of delays in treatment brought about by the pandemic. 50% of occupational therapists surveyed were supporting people affected by lasting Covid symptoms.[97]

United States

Dr. Anthony S. Fauci has described long-term COVID-19 as "...a phenomenon that is really quite real and quite extensive," but also said that the number of cases is unknown.[98]

On 23 February 2021, National Institutes of Health Director Francis Collins announced a major initiative to identify the causes and ultimately the means of prevention and treatment of people who are suffering from long COVID.[24] Part of this initiative includes the creation of the COVID-19 Project,[99] which will gather data on neurological symptoms associated with PASC.

On 28 April 2021, the Subcommittee on Health of the U.S. House of Representatives' Committee on Energy and Commerce held a hearing about long COVID.[100][101] In February 2022 it was announced that at least sixty-six hospitals and health systems had launched COVID recovery programs to aid patients who experience long term or lingering sympotoms.[102]

Public response

Some people experiencing long COVID have formed groups on social media sites.[103][104][105][106] There is an active international long COVID patient advocacy movement[107][108] which includes research led by patients themselves.[109][110] In many of these groups, individuals express frustration and their sense that their problems have been dismissed by medical professionals.[105][106]

Special populations

Children

A study from the Office for National Statistics with 20,000 participants, including children and adults, found that, in children who tested positive, at least one symptom persisted after five weeks in 9.8% of children aged two to eleven years and in 13% of children aged 12 to 16 years.[8] A 2022 University College London study in the UK, found that children ages 11-17 who had a positive PCR test for COVID were more likely to have three or more symptoms three months after their diagnosis compared to those with a negative test.[111] A study in Italy, which analyzed 129 children under the age of 18, examined health data obtained via a questionnaire between September 2020 and 1 January 2021. 53% of the group experienced COVID-19 symptoms more than 120 days after their diagnosis, and 43% were still impaired by the symptoms. Symptoms included insomnia, fatigue, muscle pain, chest tightness and pain, nasal congestion, tiredness, and difficulty concentrating.[112][113] A case report of five children in Sweden also reported symptoms (fatigue, heart palpitations, dyspnoea, headaches, muscle weakness and difficulty concentrating) persisting for 6–8 months after diagnosis.[49]

See also

References

  1. ^ a b "A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021". www.who.int.
  2. ^ a b Soriano, Joan B.; Murthy, Srinivas; Marshall, John C.; Relan, Pryanka; Diaz, Janet V. (21 December 2021). "A clinical case definition of post-COVID-19 condition by a Delphi consensus". The Lancet Infectious Diseases. 22 (4): e102–e107. doi:10.1016/S1473-3099(21)00703-9. PMC 8691845. PMID 34951953.
  3. ^ Baig AM (May 2021). "Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers". Journal of Medical Virology. 93 (5): 2555–56. doi:10.1002/jmv.26624. PMID 33095459.
  4. ^ "Long-Term Effects of COVID-19". Centers for Disease Control and Prevention. 13 November 2020. Retrieved 27 November 2020.
  5. ^ "Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE". National Institute for Health and Care Excellence. 18 December 2020. Retrieved 18 December 2020.
  6. ^ a b Al-Aly Z, Xie Y, Bowe B (June 2021). "High-dimensional characterization of post-acute sequelae of COVID-19". Nature. 594 (7862): 259–64. Bibcode:2021Natur.594..259A. doi:10.1038/s41586-021-03553-9. PMID 33887749.
  7. ^ "COVID-19 and Your Health". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 26 February 2021.
  8. ^ a b "Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021". Office for National Statistics. 1 April 2021. Retrieved 14 August 2021.
  9. ^ Taquet M, Derco Q, Luciano S, Geddes JR, Husain M, Harrison, et al. (28 September 2021). "Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19". PLOS Medicine. 20 (9): e1003773. doi:10.1371/journal.pmed.1003773. PMC 8478214. PMID 34582441.
  10. ^ a b "Researching long COVID: addressing a new global health challenge". NIHR Evidence. 12 May 2022. doi:10.3310/nihrevidence_50331.
  11. ^ Workshop on Post-Acute Sequelae of COVID-19 (Day 1). NIH.
  12. ^ "Center for Post-COVID Care | Mount Sinai - New York". Mount Sinai Health System.
  13. ^ "Delhi's Post-Covid Clinic For Recovered Patients With Fresh Symptoms Opens". NDTV.com.
  14. ^ "Post COVID-19 Rehabilitation and Recovery". Lifemark.
  15. ^ Leviner, Sherry (7 May 2021). "Recognizing the Clinical Sequelae of COVID-19 in Adults: COVID-19 Long-Haulers". The Journal for Nurse Practitioners. 17 (8): 946–949. doi:10.1016/j.nurpra.2021.05.003. ISSN 1555-4155. PMC 8103144. PMID 33976591.
  16. ^ "Nearly half of people infected with COVID-19 experienced some 'long COVID' symptoms, study finds". University of Michigan. Retrieved 15 May 2022.
  17. ^ Chen, Chen; Haupert, Spencer R.; Zimmermann, Lauren; Shi, Xu; Fritsche, Lars G.; Mukherjee, Bhramar (16 April 2022). "Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review". The Journal of Infectious Diseases: jiac136. doi:10.1093/infdis/jiac136. PMC 9047189. PMID 35429399.
  18. ^ Perego E, Callard F, Stras L, Melville-Johannesson B, Pope R, Alwan N (1 October 2020). "Why we need to keep using the patient made term "Long Covid"". The BMJ. Retrieved 18 October 2020.
  19. ^ Callard F, Perego E (January 2021). "How and why patients made Long Covid". Social Science & Medicine. 268: 113426. doi:10.1016/j.socscimed.2020.113426. ISSN 0277-9536. PMC 7539940. PMID 33199035.
  20. ^ a b c d e Brodin P (January 2021). "Immune determinants of COVID-19 disease presentation and severity". Nature Medicine. 27 (1): 28–33. doi:10.1038/s41591-020-01202-8. PMID 33442016.
  21. ^ Pearson, Catherine (14 March 2022). "We're Not Prepared For The Next Pandemic Phase: Dealing With Long COVID". HuffPost. Retrieved 15 March 2022.
  22. ^ Wu, Katherine J. (8 October 2021). "Nine Pandemic Words That Almost No One Gets Right". The Atlantic. Retrieved 15 October 2021.
  23. ^ a b "Context | COVID-19 rapid guideline: managing the long-term effects of COVID-19". National Institute for Health and Care Excellence. 18 December 2020. Retrieved 18 December 2020.
  24. ^ a b "NIH launches new initiative to study "Long COVID"". National Institutes of Health (NIH). 23 February 2021.
  25. ^ CDC (11 February 2020). "Post-COVID Conditions". Centers for Disease Control and Prevention. Retrieved 12 July 2021.
  26. ^ "Lingering Symptoms: Researchers Identify Over 50 Long-Term Effects of COVID-19". SciTechDaily. Houston Methodist. 1 September 2021. Retrieved 21 September 2021.
  27. ^ Lopez-Leon, Sandra; Wegman-Ostrosky, Talia; Perelman, Carol; Sepulveda, Rosalinda; Rebolledo, Paulina A.; Cuapio, Angelica; Villapol, Sonia (9 August 2021). "More than 50 long-term effects of COVID-19: a systematic review and meta-analysis". Scientific Reports. 11 (1): 16144. Bibcode:2021NatSR..1116144L. doi:10.1038/s41598-021-95565-8. ISSN 2045-2322. PMC 8352980. PMID 34373540.
  28. ^ a b Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. (July 2021). "Characterizing long COVID in an international cohort: 7 months of symptoms and their impact". EClinicalMedicine. 38: 101019. doi:10.1016/j.eclinm.2021.101019. PMC 8280690. PMID 34308300.
  29. ^ "COVID-19 (coronavirus): Long-term effects". Mayo Clinic. 18 August 2020. Retrieved 19 October 2020.
  30. ^ "What are the long-term health risks following COVID-19?". NewsGP. Royal Australian College of General Practitioners (RACGP). 24 June 2020. Retrieved 19 October 2020.
  31. ^ Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. (October 2020). "Long-term consequences of COVID-19: research needs". The Lancet. Infectious Diseases. 20 (10): 1115–17. doi:10.1016/S1473-3099(20)30701-5. PMC 7462626. PMID 32888409.
  32. ^ a b Chen, Stephen (10 January 2021). "Chinese study finds most patients show signs of 'long Covid' six months on". South China Morning Post. Beijing. Archived from the original on 4 May 2022. Retrieved 11 January 2021.
  33. ^ Yan, Wudan (26 November 2020). "Their Teeth Fell Out. Was It Another Covid-19 Consequence?". The New York Times.
  34. ^ Guynup, Sharon (29 December 2021). "Can COVID-19 alter your personality? Here's what brain research shows". Science. Retrieved 7 January 2022.{{cite web}}: CS1 maint: url-status (link)
  35. ^ a b Brewer K (28 January 2021). "Parosmia: 'Since I had Covid, food makes me want to vomit'". BBC News. Retrieved 29 January 2021.
  36. ^ Bowe, Benjamin; Xie, Yan; Xu, Evan; Al-Aly, Ziyad (31 August 2021). "Kidney Outcomes in Long COVID". Journal of the American Society of Nephrology. 32 (11): 2851–2862. doi:10.1681/ASN.2021060734. PMC 8806085. PMID 34470828. S2CID 237389462.
  37. ^ Rabin, Roni Caryn (5 May 2022). "Can Covid Lead to Impotence?". The New York Times. ISSN 0362-4331. Retrieved 6 May 2022.
  38. ^ Komaroff A (15 October 2020). "The tragedy of the post-COVID "long haulers"". Harvard Health. Harvard Health Publishing, Harvard Medical School. Retrieved 18 October 2020.
  39. ^ a b c "Living with Covid19. A dynamic review of the evidence around ongoing covid-19 symptoms (often called long covid)". National Institute for Health Research. 15 October 2020. doi:10.3310/themedreview_41169. Archived (PDF) from the original on 18 October 2020.
  40. ^ a b "Clinical Spectrum". COVID-19 Treatment Guidelines. National Institutes of Health. Retrieved 15 October 2021.{{cite web}}: CS1 maint: url-status (link)
  41. ^ Nordvig AS, Fong KT, Willey JZ, Thakur KT, Boehme AK, Vargas WS, et al. (April 2021). "Potential Neurologic Manifestations of COVID-19". Neurology. Clinical Practice. 11 (2): e135–e146. doi:10.1212/CPJ.0000000000000897. PMC 8032406. PMID 33842082.
  42. ^ a b Servick K (8 April 2020). "For survivors of severe COVID-19, beating the virus is just the beginning". Science. doi:10.1126/science.abc1486. ISSN 0036-8075.
  43. ^ Tanner C (12 August 2020). "All we know so far about 'long haul' Covid – estimated to affect 600,000 people in the UK". inews. Retrieved 19 October 2020. i spoke to Professor Tim Spector of King's College London who developed the Covid-19 tracker app
  44. ^ Yu-Tao X (2014). "Outcomes of SARS survivors in China: Not only physical and psychiatric co-morbidities". East Asian Archives of Psychiatry. 24 (1): 37–38. doi:10.3316/informit.231710814201582 (inactive 28 February 2022). PMID 24676486.{{cite journal}}: CS1 maint: DOI inactive as of February 2022 (link)
  45. ^ a b c "The prevalence of long COVID symptoms and COVID-19 complications". Office of National Statistics UK. December 2020.
  46. ^ a b Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. (July 2020). "Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March–June 2020". MMWR. Morbidity and Mortality Weekly Report. 69 (30): 993–98. doi:10.15585/mmwr.mm6930e1. PMC 7392393. PMID 32730238.
  47. ^ Davis N (16 December 2020). "Long Covid alarm as 21% report symptoms after five weeks". The Guardian. Retrieved 28 December 2020.
  48. ^ a b c Herman J (27 December 2020). "I'm a consultant in infectious diseases. 'Long Covid' is anything but a mild illness". The Guardian. Retrieved 28 December 2020.
  49. ^ a b Ludvigsson JF (March 2021). "Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19". Acta Paediatrica. 110 (3): 914–21. doi:10.1111/apa.15673. PMC 7753397. PMID 33205450.
  50. ^ Simpson F, Lokugamage A (16 October 2020). "Counting long covid in children". The BMJ. Retrieved 18 October 2020.
  51. ^ a b Fitzgerald B (14 October 2020). "Long-haul COVID-19 patients will need special treatment and extra support, according to new guide for GPs". ABC News. Australian Broadcasting Corporation. Retrieved 19 October 2020.
  52. ^ Ross JM, Seiler J, Meisner J, Tolentino L (1 September 2020). "Summary of COVID-19 Long Term Health Effects: Emerging evidence and Ongoing Investigation" (PDF). University of Washington. Retrieved 15 October 2020.
  53. ^ "How long does COVID-19 last?". UK COVID Symptom Study. 6 June 2020. Retrieved 15 October 2020.
  54. ^ Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. (January 2021). "6-month consequences of COVID-19 in patients discharged from hospital: a cohort study". Lancet. 397 (10270): 220–32. doi:10.1016/S0140-6736(20)32656-8. PMC 7833295. PMID 33428867.
  55. ^ Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. (May 2021). "Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers"". Annals of Clinical and Translational Neurology. 8 (5): 1073–85. doi:10.1002/acn3.51350. PMC 8108421. PMID 33755344.
  56. ^ Belluck P (23 March 2021). "They Had Mild Covid. Then Their Serious Symptoms Kicked In". The New York Times. ISSN 0362-4331. Archived from the original on 28 December 2021. Retrieved 27 March 2021.
  57. ^ Ayoubkhani, Daniel; et al. (15 January 2021). "Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study". medaRxiv. doi:10.1101/2021.01.15.21249885. S2CID 231610175.
  58. ^ Salim N (6 March 2021). "Indonesians open up about the impacts of long COVID, one year since the country's first case". ABC News. Australian Broadcasting Corporation. Retrieved 6 March 2021.
  59. ^ Nasserie T, Hittle M, Goodman SN (May 2021). "Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review". JAMA Network Open. 4 (5): e2111417. doi:10.1001/jamanetworkopen.2021.11417. PMC 8155823. PMID 34037731.
  60. ^ "Half of young adults with COVID-19 have persistent symptoms after 6 months". medicalxpress.com. Retrieved 10 July 2021.
  61. ^ Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. (June 2021). "Long COVID in a prospective cohort of home-isolated patients". Nature Medicine. 27 (9): 1607–1613. doi:10.1038/s41591-021-01433-3. PMC 8440190. PMID 34163090. S2CID 235625772.
  62. ^ Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, Zhang X (28 August 2021). "1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study". The Lancet. 398 (10302): 747–58. doi:10.1016/S0140-6736(21)01755-4. ISSN 0140-6736. PMC 8389999. PMID 34454673. S2CID 237308841.
  63. ^ Parker-Pope, Tara (16 August 2021). "Can the Vaccinated Develop Long Covid After a Breakthrough Infection?". The New York Times. ISSN 0362-4331. Archived from the original on 28 December 2021. Retrieved 17 August 2021.
  64. ^ Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. (July 2021). "Covid-19 Breakthrough Infections in Vaccinated Health Care Workers". The New England Journal of Medicine. 385 (16): 1474–1484. doi:10.1056/NEJMoa2109072. PMC 8362591. PMID 34320281.
  65. ^ Antonelli, Michela; Penfold, Rose S.; Merino, Jordi; Sudre, Carole H.; Molteni, Erika; Berry, Sarah; Canas, Liane S.; Graham, Mark S.; Klaser, Kerstin; Modat, Marc; Murray, Benjamin; Kerfoot, Eric; Chen, Liyuan; Deng, Jie; Österdahl, Marc F.; Cheetham, Nathan J.; Drew, David A.; Nguyen, Long H.; Pujol, Joan Capdevila; Hu, Christina; Selvachandran, Somesh; Polidori, Lorenzo; May, Anna; Wolf, Jonathan; Chan, Andrew T.; Hammers, Alexander; Duncan, Emma L.; Spector, Tim D.; Ourselin, Sebastien; Steves, Claire J. (1 September 2021). "Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study". The Lancet Infectious Diseases. 22 (1): 43–55. doi:10.1016/S1473-3099(21)00460-6. ISSN 1473-3099. PMC 8409907. PMID 34480857.
  66. ^ Reardon, Sara (27 May 2022). "Long COVID Risk Falls Only Slightly after Vaccination". Scientific American. Retrieved 27 May 2022.
  67. ^ Fernández-de-las-Peñas, César; Palacios-Ceña, Domingo; Gómez-Mayordomo, Víctor; Florencio, Lidiane L; Cuadrado, María L.; Plaza-Manzano, Gustavo; Navarro-Santana, Marcos (October 2021). "Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis". European Journal of Internal Medicine. 92: 55–70. doi:10.1016/j.ejim.2021.06.009. PMC 8206636. PMID 34167876.
  68. ^ a b c d e f Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L (August 2020). "Management of post-acute covid-19 in primary care". BMJ. 370: m3026. doi:10.1136/bmj.m3026. PMID 32784198. S2CID 221097768.
  69. ^ Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. (April 2021). "Post-acute COVID-19 syndrome". Nature Medicine. 27 (4): 601–15. doi:10.1038/s41591-021-01283-z. PMC 8893149. PMID 33753937.
  70. ^ Mahase E (October 2020). "Long covid could be four different syndromes, review suggests". BMJ. 371: m3981. doi:10.1136/bmj.m3981. PMID 33055076. S2CID 222348080. Lay summaryBBC News (15 October 2020). {{cite journal}}: Cite uses deprecated parameter |lay-url= (help)
  71. ^ Taquet M, Luciano S, Geddes JR, Harrison PJ (February 2021). "Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA". The Lancet. Psychiatry. 8 (2): 130–40. doi:10.1016/S2215-0366(20)30462-4. PMC 7820108. PMID 33181098.
  72. ^ Pretorius, Etheresia; Vlok, Mare; Venter, Chantelle; Bezuidenhout, Johannes A.; Laubscher, Gert Jacobus; Steenkamp, Janami; Kell, Douglas B. (23 August 2021). "Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin". Cardiovascular Diabetology. 20 (1): 172. doi:10.1186/s12933-021-01359-7. ISSN 1475-2840. PMC 8381139. PMID 34425843.
  73. ^ Arthur, John M.; Forrest, J. Craig; Boehme, Karl W.; Kennedy, Joshua L.; Owens, Shana; Herzog, Christian; Liu, Juan; Harville, Terry O. (3 September 2021). "Development of ACE2 autoantibodies after SARS-CoV-2 infection". PLOS ONE. 16 (9): e0257016. Bibcode:2021PLoSO..1657016A. doi:10.1371/journal.pone.0257016. ISSN 1932-6203. PMC 8415618. PMID 34478478.
  74. ^ Wallukat, Gerd; Hohberger, Bettina; Wenzel, Katrin; Fürst, Julia; Schulze-Rothe, Sarah; Wallukat, Anne; Hönicke, Anne-Sophie; Müller, Johannes (16 April 2021). "Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms". Journal of Translational Autoimmunity. 4: 100100. doi:10.1016/j.jtauto.2021.100100. ISSN 2589-9090. PMC 8049853. PMID 33880442.
  75. ^ Bertin, Daniel; Kaphan, Elsa; Weber, Samuel; Babacci, Benjamin; Arcani, Robin; Faucher, Benoit; Ménard, Amélie; Brodovitch, Alexandre; Mege, Jean Louis; Bardin, Nathalie (2021). "Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome". International Journal of Infectious Diseases. 113: 23–25. doi:10.1016/j.ijid.2021.09.079. ISSN 1201-9712. PMC 8487460. PMID 34614444.
  76. ^ Dunham J (5 May 2021). "Some COVID-19 long-haulers are developing a 'devastating' syndrome". CTV News. Retrieved 7 May 2021.
  77. ^ Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. (April 2021). "Attributes and predictors of long COVID". Nature Medicine. 27 (4): 626–31. doi:10.1038/s41591-021-01292-y. PMC 7611399. PMID 33692530.
  78. ^ Gallagher J (21 October 2020). "Long Covid: Who is more likely to get it?". BBC. Retrieved 21 October 2020.
  79. ^ "New research identifies those most at risk from 'long COVID'". King's College London. 21 October 2020. Retrieved 22 October 2020.
  80. ^ "Obesity linked to long Covid-19, RAK hospital study finds". Khaleej Times. 12 August 2021. Retrieved 12 August 2021.
  81. ^ Graziano P (2021). "Sex and COVID-19: A Protective Role for Reproductive Steroids". Trends in Endocrinology & Metabolism. 32 (1): 3–6. doi:10.1016/j.tem.2020.11.004. PMC 7649655. PMID 33229187.
  82. ^ Bjugstad K. "Sex Hormones May Be Key Weaponry in the Fight Against COVID-19". Endocrineweb. Retrieved 22 February 2021.
  83. ^ Crump, Ed (14 June 2021). "Polarean: Durham company's lung imaging technique could help long-haul COVID patients". ABC11 Raleigh-Durham. Retrieved 29 September 2021.
  84. ^ a b Marshall, Helen; Stewart, Neil J.; Chan, Ho-Fung; Rao, Madhwesha; Norquay, Graham; Wild, Jim M. (February 2021). "In vivo methods and applications of xenon-129 magnetic resonance". Progress in Nuclear Magnetic Resonance Spectroscopy. 122: 42–62. doi:10.1016/j.pnmrs.2020.11.002. ISSN 0079-6565. PMC 7933823. PMID 33632417. S2CID 230595631.
  85. ^ "Basic Principles of Hyperpolarized Gas". Polarean Imaging plc. Retrieved 29 September 2021.
  86. ^ Crellin, Zac (17 December 2021). "Long COVID looms as Australia grapples with Omicron". The New Daily. Retrieved 18 December 2021.
  87. ^ "International Severe Acute Respiratory and emerging Infection Consortium". ISARIC. Retrieved 19 February 2022.
  88. ^ Cookson C (15 October 2020). "'Long Covid' symptoms can last for months". Financial Times. Retrieved 15 October 2020.
  89. ^ a b Greenhalgh T (21 September 2020). "Covid-19: An open letter to the UK's chief medical officers". The BMJ. Retrieved 19 October 2020.
  90. ^ "NHS to offer 'long covid' sufferers help at specialist centres". NHS England. 7 October 2020. Retrieved 19 October 2020.
  91. ^ "Your COVID Recovery". Your COVID Recovery. Archived from the original on 20 October 2020. Retrieved 19 October 2020.
  92. ^ "UCLH opens second 'long Covid' clinic for patients with neurological complications". University College London NHS Foundation Trust. Retrieved 19 December 2020.
  93. ^ Brennan, Sharon (25 March 2021). "'No urgency, no plan' for long covid". Health Service Journal. Retrieved 10 May 2021.
  94. ^ "NICE, RCGP and SIGN publish guideline on managing the long-term effects of COVID-19". NICE. 18 December 2020. Retrieved 28 December 2020.
  95. ^ Gorna, Robin; MacDermott, Nathalie; Rayner, Clare; O'Hara, Margaret; Evans, Sophie; Agyen, Lisa; Nutland, Will; Rogers, Natalie; Hastie, Claire (February 2021). "Long COVID guidelines need to reflect lived experience". The Lancet. 397 (10273): 455–57. doi:10.1016/S0140-6736(20)32705-7. PMC 7755576. PMID 33357467.
  96. ^ Collins, Annabelle (11 November 2021). "Unions guilty of a 'moral failure' in poor support for staff with long covid". Health Service Journal. Retrieved 27 December 2021.
  97. ^ "Fears of long-Covid crisis as demand for rehabilitation services surges". Independent. 21 May 2022. Retrieved 22 May 2022.
  98. ^ Belluck P (4 December 2020). "Covid Survivors With Long-Term Symptoms Need Urgent Attention, Experts Say". The New York Times. ISSN 0362-4331. Retrieved 18 February 2021.
  99. ^ "COVID-19 Neuro Databank-Biobank". NYU Langone Health. Retrieved 26 February 2021.
  100. ^ "The Long Haul: Forging a Path through the Lingering Effects of COVID-19". YouTube. 29 April 2021. Retrieved 16 May 2021.{{cite web}}: CS1 maint: url-status (link)
  101. ^ Smith CL (15 May 2021). "Here's What Happened When I Told Congress The Black And Ugly Truth About Long COVID". HuffPost. Retrieved 16 May 2021.
  102. ^ Carbajal, Erica; Gleeson, Cailey (9 February 2022). "66 hospitals, health systems that have launched post-COVID-19 clinics". Beckers Hospital Review. Retrieved 15 March 2022.
  103. ^ "Long COVID Support Group". Facebook.
  104. ^ Blazonis S (27 November 2020). "Facebook Group Created by Tampa Man Aims to Connect COVID-19 Long Haulers". www.baynews9.com. Retrieved 29 November 2020.
  105. ^ a b Witvliet MG (27 November 2020). "Here's how it feels when COVID-19 symptoms last for months". PBS NewsHour. Retrieved 29 November 2020.
  106. ^ a b "Across Southeast Asia, Long COVID Haunts Pandemic Survivors". New Naratif. 25 January 2022. Retrieved 31 January 2022.
  107. ^ Macnamara K. "The Covid 'longhaulers' behind a global patient movement". AFP.
  108. ^ Sifferlin A (11 November 2020). "How Covid-19 Long Haulers Created a Movement".
  109. ^ "Patient-Led Research Patient Led Research Collaborative for Long COVID Long Covid". Patient Led Research Collaborative.
  110. ^ Callard F, Perego E (January 2021). "How and why patients made Long Covid". Social Science & Medicine. 268: 113426. doi:10.1016/j.socscimed.2020.113426. ISSN 0277-9536. PMC 7539940. PMID 33199035.
  111. ^ "Long COVID and kids: more research is urgently needed". Nature. 183 (602): 183. 8 February 2022. Bibcode:2022Natur.602..183.. doi:10.1038/d41586-022-00334-w. PMID 35136225. S2CID 246678864. Retrieved 16 February 2022.
  112. ^ Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, Valentini P (July 2021). "Preliminary evidence on long COVID in children". Acta Paediatrica. 110 (7): 2208–11. doi:10.1111/apa.15870. PMC 8251440. PMID 33835507.
  113. ^ Lewis D (July 2021). "Long COVID and kids: scientists race to find answers". Nature. 595 (7868): 482–83. Bibcode:2021Natur.595..482L. doi:10.1038/d41586-021-01935-7. PMID 34262190. S2CID 235906450.

Further reading

News

Journal articles

External links

  • Long Covid on YouTube (21 October 2020) – UK Government film about long COVID.
  • Living with Covid19. A review of what is known about long COVID by the NIHR.
  • "PHOSP". Home. University of Leicester. The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a consortium of leading researchers and clinicians from across the UK working together to understand and improve long-term health outcomes for patients who have been in hospital with confirmed or suspected COVID-19.
This page is based on the copyrighted Wikipedia article: Long COVID. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.